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replicating  th e  in frequen t (1 in  50,000) b u t sim ply inherited  
h u m an  genetic disease cystic fibrosis, and  som e of th e  h em o ­
globinopath ies (1 in  100-1,000), and  progressing to  using th e  
m e th o d  to  decipher th e  genetic com plexities of m uch  m ore 
com m on b u t also m uch  m ore com plex conditions, such as a th ­
erosclerosis (1 in  2) and  hypertension  (1 in  5)30, We h ad  an  im ­
p o rtan t concep tual change early in  our studies of th e  genetic 
com plexities of h ypertension . This was a shift from  considering 
absence of gene fu nc tion  as a p rincipal cause of disease (as is 
th e  case w ith  th e  u n co m m o n  disease cystic fibrosis) to  consid­
ering th e  possibility th a t inherited  quan tita tive  variations (per­
haps even norm al variations) in  gene expression m igh t be m ore 
im p o rtan t in  causing th e  com plex com m on conditions. To in ­
vestigate this possibility  experim entally , we devised a 'gene- 
titra tio n ' m ethod , in  w hich  tw o com plem entary  form s of 
hom ologous recom bination  are used to  vary th e  num ber of 
copies of a candidate gene from  one th ro u g h  four31. The 'one-
copy' anim als are heterozygous for a w ild-type allele and  a 
deleted copy. The 'th ree-copy ' and  'four-copy' anim als use a 
com plete tan d em  gene duplica tion  rem in iscen t of Hp2. In  the  
m ost d ram atic of these experim ents, th e  resulting  gene expres­
sion varies linearly  w ith  copy num ber from  14x  to  2 x  norm al. 
W ith  th e  cu rren t em phasis on  single-nucleotide po lym or­
phism s and  functional genom ics, it is likely th a t m ice ob tained  
by hom ologous recom bination  will p rove to  be of great value in  
establishing w hether a genotype associated in  h um ans w ith  a 
com plex pheno type could in  fact cause th e  condition . 
O bviously I co n tinue  to  enjoy  using  th e  too l for w h ich  
we are being  h o n o red  to  solve problem s of in terest to  me. 
A nd w hen  I open  any  cu rren t issue of th e  m ain  journals cover­
ing  biological science, I am  very likely to  have th e  vicarious 
en joym en t of seeing som e o ther investigators ' use of h o m o lo ­
gous recom bina tion  to  m odify  the ir chosen  gene in  the  
m ouse genom e.
Generating mice with targeted mutations
M utational analysis is one of th e  m ost .......
inform ative approaches available for the  
study  of com plex biological processes. It 
has been  particularly  successful in  th e  analysis of th e  biology 
of bacteria, yeast, th e  nem atode w orm  Caenorhabditis elegans 
and  th e  fru it fly Drosophila melanogaster. Extension of th is ap ­
p roach  to  th e  m ouse, th o u g h  in form ative, was far less success­
ful relative to  w hat has been  achieved w ith  these sim pler 
m odel organism s. This is because it is n o t num erically  practical 
in  m ice to  use ran d o m  m utagenesis to  isolate m u ta tions th a t 
affect a specified biological process of in terest. N onetheless, b i­
ological p h en o m en a  such as a sophisticated  im m une  response, 
cancer, vascular disease or h igher-order cognitive function , to  
m en tio n  just a few, m ust be analyzed in  organism s th a t show  
such p h enom ena , and  for th is reason geneticists and  o ther re­
searchers have tu rn ed  to  th e  m ouse. Gene targeting, th e  m eans 
for creating  m ice w ith  designed m u ta tions in  a lm ost any 
gene32, was developed as an  alternative to  th e  im practical use 
of random  m utagenesis for pu rsu ing  genetic analysis in  th e  
m ouse. N ow gene targeting  has advanced th e  genom ic m an ip ­
u la tions possible in  m ice to  a level th a t can be m atched  on ly  in  
far sim pler organism s such as bacteria and  yeast.
The developm ent of gene targeting  in  m ice required  th e  so­
lu tio n  to  tw o problem s: How to  p roduce a specific m u ta tio n  in  
a chosen  gene in  cu ltu red  m am m alian  cells, and  how  to  tran s­
fer th is m u ta tio n  to  th e  m ouse germ  line, Oliver Sm ithies' lab­
oratory  and  m ine  w orked indep en d en tly  on  solu tions to  th e  
first problem , M artin  Evans' laboratory  provided th e  basis for a 
so lu tion  to  th e  second problem .
Early experiments
O ur en try  in to  w h a t becam e th e  field of gene targeting  began 
in  1977, At th a t tim e, I was a ttem p tin g  to  im prove th e  effi­
ciency w ith  w h ich  new  genes could  be in troduced  in to  m am ­
m alian  cells. It h ad  just been  dem onstra ted  by  W igler and  Axel 
th a t cu ltu red  m am m alian  cells deficient in  th ym id ine  kinase 
{Thr) could  be transform ed to  Tk+ status by  th e  in tro d u c tio n  of 
a functional copy of th e  herpes th ym id ine  kinase gene 
(HSV-tk)33. A lthough  an  im p o rtan t advance for th e  field of so­
m atic  cell genetics, the ir p ro toco l—th e  use of calcium  phos-
M ario  R. C a pec c h i
.......  p h a te  co-precip ita tion  to  in troduce the
DNA in to  cu ltu red  cells—was n o t effi­
cient, W ith  th is m ethod , incorpora tion  
of functional copies of tk occurred in  on ly  one per m illion  cells 
exposed to  th e  D N A -calcium  phospha te  co-precipitate. U sing 
a sim ilar selection  schem e, I sough t to  determ ine w hether I 
could in troduce  a functional tk in to  Tkr cells u sing  very fine 
glass needles to  in jec t DNA directly  in to  nucle i34. This p roce­
dure proved extrem ely  efficient. O ne cell in  th ree th a t received 
th e  DNA stably passed th e  functional tk to  its daugh ter cells. 
The h igh  efficiency of DNA transfer by  m icro in jec tion  m ade it 
practical for investigators to  generate transgenic m ice co n ta in ­
ing  ran d o m  insertions of exogenous DNA, This was accom ­
p lished by in jec tion  of th e  desired DNA in to  nuclei of one-cell 
zygotes and  allow ing these em bryos to  com e to  term  after sur­
gical transfer to  foster m o thers35^39.
Efficient functional transfer of HSV-tk in to  cells required  th a t 
th e  injected tk be linked to  o ther short viral DNA sequences34. It 
seem ed plausible th a t h igh ly  evolved viral genom es m igh t con ­
ta in  bits of DNA th a t enhance  their ability to  establish th e m ­
selves w ith in  m am m alian  cell genom es, I searched th e  genom e 
of th e  lytic sim ian virus SV40 for th e  presence of such se­
quences and  found  one near th e  origin of viral DNA replication. 
W hen  linked to  HSV-tk, it increased th e  transform ing  capacity 
of th e  in jected  tk by 100-fold, I show ed th a t th e  enhancem en t 
did n o t seem to  result from  in d ep en d en t replication  of th e  in ­
jected HSV-tk DNA as an  extra-chrom osom al plasm id, bu t 
ra ther th a t th e  efficiency-enhancing sequence was either
Fig . 1 Regenera­
tion of a functional 
ned  by gene target­
ing. The recipient 
cell contains a de­
fective ned  with a 
deletion mutation 
(*). The targeting 
vector contains a 5' 
point mutation. With a frequency of 1 in 1,000 cells receiving an injection, the 
deletion mutation in the chromosomal copy of ned  is corrected with informa­
tion supplied by the targeting vector.
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increasing th e  frequency w ith  w hich th e  exogenous DNA was 
in tegrated  in to  th e  host genom e, or increasing th e  probability  
th a t tk, once integrated, was being expressed in  th e  recipient 
cells. These experim ents w ere com pleted before th e  idea of gene 
expression ‘enhancers’ had  em erged and  con tribu ted  to  th e  de­
fin ition  of these special DNA sequences40. The em erging idea of 
enhancers p rofoundly  influenced our con tribu tions to  th e  de­
velopm ent of gene targeting by alerting us to  th e  im portance of 
using appropriate enhancers to  m ediate expression of new ly in ­
troduced  selectable genes regardless of th e  in h e ren t expression 
characteristics of th e  h o st site to  w hich  th ey  were targeted.
Homologous recombination
The observation  I found  m ost fascinating  from  these  early DNA 
m icro in jec tion  experim ents was th a t w hen  m any  copies of th e  
tk plasm id w ere in jected  in to  cells, th ey  w ere in teg rated  in  only 
one  or tw o loci w ith in  any host cell’s chrom osom e, and  th a t 
m u ltip le  copies at those  random  sites w ere always presen t as 
head-to -ta il concatem ers. W e reasoned th a t such h igh ly  or­
dered concatem ers could on ly  be generated  either by replica­
tio n  (for exam ple, a rolling circie-type m echanism ) or by 
hom ologous recom bination  betw een plasm ids. W e proved th a t 
th ey  w ere generated  by hom ologous recom bina tion41. This 
conclusion  was very significant because it d em onstra ted  th a t 
m am m alian  som atic cells con ta ined  an  efficient enzym atic 
m ach inery  for m ed ia ting  hom ologous recom bination . The effi­
ciency of th is  m ach inery  becam e ev iden t from  th e  observation 
th a t w hen  m ore th a n  100 tk  p lasm id m olecules w ere in jected  
per cell, th ey  were all inco rpora ted  in to  a single, ordered, head- 
to-ta il concatem er. It was im m ediately  apparen t th a t if we 
could harness th is efficient m achinery  to  accom plish h o m o lo ­
gous recom bination  betw een a new ly in troduced  DNA m ole­
cule of ou r choice and  th e  sam e DNA sequence in  a recip ien t 
cell’s genom e, w e w ould  have th e  ability  to  m u ta te  or m odify 
alm ost any  cellular gene in  any  chosen  way.
O ur n ex t step in  th e  quest for gene targeting  required  our 
becom ing fam iliar w ith  th is  m achinery; specifically, w ith  its 
substrate preferences and  reaction  products. By exam ining  
recom bination  betw een co-injected DNA m olecules, we 
learned, am ong  o th er th ings, th a t linear DNA m olecules 
w ere th e  preferred substrate for hom ologous recom bination ; 
th a t recom bination  was cell cycle-dependent, show ing a 
peak of activity in  early S phase; and  th a t a lthough  b o th  recip­
rocal and  nonreciprocal exchanges occurred, th ere  was a dis­
tin c t bias tow ard  th e  la tte r42-44. These results con tribu ted  
substantially  to  our choice of experim ental design for th e  nex t 
stage of th is  quest: th e  detec tion  of hom ologous recom bina­
tio n  betw een new ly in troduced , exogenous DNA and  its ch ro ­
m osom e hom olog.
In 1980, we subm itted  a g ran t p roposal to  th e  N ational 
In s titu tes  of H ealth  to  tes t th e  feasibility  of gene targeting  
in  m am m alian  cells; these  experim en ts w ere rejected  on 
th e  g rounds th a t th e re  was on ly  a van ish ing ly  sm all p robab il­
ity  th a t th e  new ly in tro d u ced  DNA w ould  find  its m atch in g  
sequence w ith in  a h o st cell genom e. D espite th e  rejection , 
I decided to  co n tin u e  th is  line of exp erim en ta tio n . Aware th a t 
th e  frequency  o f gene ta rge ting  w as likely to  be low, and  th a t 
th e  far m ore  com m on  com petitive  reaction  w ould  be inser­
tio n  of th e  targeting  vector at various sites o th e r th a n  th e  ta r­
get locus, we p roposed  to  use selection  to  e lim ina te  cells n o t 
co n ta in in g  th e  desired hom ologous reco m b in a tio n  products. 
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Fig. 2 Disruption of Hprt by gene targeting. The vector contains Hprt se­
quences disrupted in the eighth exon by neo'. After homologous pairing 
between the vector and genomic sequences, a homologous recombina­
tion event replaces the genomic sequence with vector sequences contain­
ing neo'. These cells are able to grow in medium containing the drugs 
G418 and 6-TG.
ta rget sites. The first step of th is  schem e required  genera tion  
of cell lines co n ta in in g  ran d o m  in sertio n s of a defective 
neom ycin -resis tance  gene (neo1) co n ta in in g  either a de letion  
or a p o in t m u ta tio n . In  th e  second step, ta rget vector DNA 
carrying defective neo? genes w ith  d ifferen t m u ta tio n s  was in ­
troduced  in to  cells of those  lines. H om ologous recom bina tion  
betw een neo' sequences in  th e  ta rge ting  vecto r and  rec ip ien t 
genom e could  genera te  a fu n c tio n a l neo' from  th e  tw o defec­
tive parts, p roduc ing  cells resistan t to  th e  drug G418, w h ich  is 
le tha l to  cells w ith o u t a fu n c tio n a l neo'.
In th e  first step, we generated  recip ien t cell lines con ta in ing  
single copies of th e  defective neo', lines con ta in ing  m ultip le  
copies of th e  gene in  head-to-tail concatem ers and, by in h ib it­
ing  concatem er form ation , lines w ith  m ultip le  defective neo' 
targets, each located on  separate chrom osom es. These different 
recip ient cell lines allowed us to  evaluate how  th e  n u m b er and  
location  of targets w ith in  th e  recip ien t cell’s genom e in flu ­
enced th e  targeting  frequency. By 1984 we had  good evidence 
th a t gene targeting  in  cu ltu red  m am m alian  cells was indeed  
possible45. At th is tim e  I resubm itted  our g ran t to  th e  same 
N ational Institu tes of H ealth  study section th a t h ad  rejected 
our earlier g ran t proposal and  th e ir critique began w ith  th e  
phrase "W e are glad th a t you d id n 't follow  our advice."
To our delight, correction of th e  defective chrom osom al neo' 
occurred at an absolu te frequency of 1 per 1,000 cells receiving 
an in jection . This frequency was n o t on ly  h igher th a n  we ex­
pected, bu t allowed us to  accom plish m ultip le  analyses 
of th e  experim ental param eters th a t could in fluence th e  gene- 
targeting  reaction44. An add itional im p o rtan t lesson from  these 
experim ents was th a t all chrom osom al target positions 
analyzed seem ed to  be equally accessible to  th e  hom ologous 
recom bination  m achinery , ind ica ting  th a t a large fraction  of 
th e  m ouse genom e could be m odified  by gene targeting .
At th is tim e, O liver Sm ithies and  his colleagues reported  
th e ir  classic experim ent of targeted  m odification  of th e  
P-globin locus in  cultu red  m am m alian  cells18. This elegant ex­
perim en t dem onstra ted  th a t it was feasible to  d isrup t an en ­
dogenous gene in  cultured  m am m alian  cells. Having 
established th a t gene targeting  could be achieved in  cultured  
m am m alian  cells and  hav ing  determ ined  som e of th e  param e­
ters th a t in fluenced  its frequency, we w ere ready to  ex tend  th e  
approach  to  th e  w hole m ouse. The low frequency of targeted
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Fig. 3 The positive-negative selection procedure used to enrich for ES 
cells containing a targeted disruption of gene X. a, The replacement- 
type vector contains an insertion of neo' in an exon of gene X and a 
linked HSV-tk at one end. It is shown pairing with a chromosomal copy of 
gene X. Homologous recombination between the targeting vector and 
the cognate chromosomal gene results in the disruption of one genomic 
copy of gene X and the loss of the vector's HSV-tk. Cells in which this 
event has occurred will be X+'~, neo'*, HSV-tk~ and will be resistant to both 
G418 and FIAU. b, Integration of the targeting vector at a random site of 
the ES cell genome by non-homologous recombination. Because non- 
homologous insertion of exogenous DNA into the chromosome occurs 
through the ends of the linearized DNA, HSV-tk will remain linked to 
neo'. Cells derived from this type of recombination event will be X+,+, 
neo'* and HSV-tk* and therefore resistant to G418 but killed by FIAU. The 
nucleoside analog FIAU specifically kills cells with functional HSV-tk 
genes, but is not toxic to cells with only cellular Tk.
hom ologous reco m b in a tio n  relative to  ran d o m  in teg ra tio n  of 
th e  ta rg e tin g  vec to r in to  th e  rec ip ien t cell genom e m ade  it 
im prac tica l to  a ttem p t gene ta rg e tin g  d irectly  in  one-cell 
m ouse  zygotes. Instead , it seem ed ou r best o p tio n  was to  do 
gene ta rg e tin g  in  cu ltu red  em bryo-derived  stem  (ES) cells, 
from  w h ich  th e  relatively  rare ta rgeted  reco m b in an ts  w ou ld  
be selected an d  purified . T hese purified  cells, w h en  subse­
q u en tly  in tro d u ced  in to  a p re im p lan ta tio n  em bryo  an d  al­
low ed to  m atu re  in  a foster m o th e r, w ou ld  co n tr ib u te  to  th e  
fo rm atio n  of all tissues of th e  m ouse, in c lu d in g  th e  germ  line.
Gene targeting in ES cells
At a G ordon  C onference in  th e  sum m er of 1 9 8 4 ,1 h eard  a d is­
cussion  from  a m em ber of M artin  Evans' labo ra to ry  ab o u t ES 
cells. T hey seem ed m u ch  m ore  p rom ising  in  th e ir  p o ten tia l to 
c o n tr ib u te  to  th e  fo rm a tio n  of th e  germ  line  th a n  th e  p rev i­
ously  characterized  em bryona l carcinom a (EC) cells12,15. In  th e  
w in te r of 1985, m y  w ife an d  I spen t a w eek in  M artin  Evans' 
labo ra to ry  lea rn in g  h o w  to  derive, cu ltu re  an d  genera te  
m ouse  ch im eras from  these  cells.
In  th e  b eg in n in g  of 1986, ou r effort sw itched  to  do ing  
gene ta rg e tin g  experim en ts in  ES cells. W e also decided  to  use 
e lec tro p o ra tio n  as th e  m eans of in tro d u c in g  o u r ta rge ting  
vectors in to  ES cells. A lthough  m ic ro in jec tio n  is orders of 
m ag n itu d e  m ore  effic ien t th a n  e lec tro p o ra tio n  as a m eans for 
gen era tin g  cells w ith  targeted  m u ta tio n s , in jec tio n s m u s t be 
done  one  cell at a tim e. W ith  e lec tropo ra tion , we could  in tro ­
duce th e  ta rge ting  vecto r in to  1 X 10' cells in  a single experi­
m en t, easily p ro d u c in g  large num bers  of tran sfo rm ed  cells 
even  w ith  th e  low er efficiency.
To rigorously  d e te rm ine  th e  q u an tita tiv e  efficiency of gene 
ta rg e tin g  in  ES, we chose as o u r ta rge t locus th e  hypo x an - 
th in e  p hospho ribosy l transferase gene (Hprt). There w ere tw o 
m a in  reasons for th is choice. As Hprt is located  o n  th e  X ch ro ­
m osom e an d  th e  ES cell line  th a t  we w ere using  was derived 
from  a m ale m ouse, o n ly  a single Hprt locus h ad  to  be d is­
ru p ted  to  y ield  H p rt cell lines. M oreover, a good  p ro toco l for 
selecting  cells w ith  d isrup ted  Hprt genes existed, based o n  th e  
drug  6 -th io g u an in e  (6-TG), w h ich  kills cells w ith  a fu n c tio n a l 
Hprt. The stra tegy  w e used was to  genera te  a gene-targeting  
vecto r th a t  co n ta in ed  a n  Hprt genom ic  sequence th a t  was 
d isrup ted  in  an  exon  by in se rtio n  of neo1 (Fig. 2). H om ologous 
reco m b in a tio n  betw een  th is  ta rg e tin g  vec to r an d  th e  ES cell 
ch rom osom al Hprt w ou ld  genera te  H p rt cells th a t  w ou ld  be 
res is tan t to  g row th  in  m ed iu m  co n ta in in g  b o th  6-TG (killing 
H p r t cells) an d  G418 (killing cells lacking neo1). All lines g en ­
era ted  from  cells selected in  th is w ay lost Hprt fu n c tio n  as a 
resu lt of gene-targeted  d is ru p tio n  of th e  Hprt locus46. The 
H prt locus prov ided  an  ideal locus to  fu rth e r tes t m an y  v a ri­
ables th a t  cou ld  p o ten tia lly  in fluence  th e  ta rg e tin g  effi­
c iency46-19.
Because we foresaw  th a t  neo1 w ou ld  probab ly  be used as a 
positive selectable gene for th e  d is ru p tio n  of m an y  genes in  
ES cells, it was essen tia l th a t  its expression  be m ed ia ted  by an  
en h an ce r th a t  w ou ld  fu n c tio n  regardless of its lo ca tion  
w ith in  th e  ES cell genom e. Here ou r previous experience w ith  
enhancers  an d  th e  tran sfo rm a tio n  of cu ltu red  m ouse  cells 
p roved  of value. W e knew  from  those  experim en ts th a t  th e  
activ ities of p ro m o te r-e n h a n c e r configura tions are very cell- 
specific. To encourage  such  s trong  neo1 expression  in  ES cells, 
we chose to  drive it w ith  a dup lica ted , m u ta ted  po lyom a virus 
en h an ce r selected for s trong  expression  in  m ouse em bryonal 
carc inom a cells46. S ubsequently , th e  stra tegy  described above 
of using  neo1 d riven  by an  en h an ce r th a t  allows strong  expres­
sion  in  ES cells, in d e p e n d e n t of ch rom osom al location , has 
becom e th e  s tandard  for d is ru p tio n  of m o st genes in  ES cells.
T he experim en ts described above show ed th a t  ES cells w ere 
good rec ip ien t hosts, able to  m ed ia te  hom ologous recom bi­
n a tio n  betw een  th e  ta rg e tin g  vecto r an d  th e  cognate  ch ro m o ­
som al sequence. In  ad d itio n , th e  d rug-selection  p ro toco ls 
requ ired  to  iden tify  ES cell lines co n ta in in g  th e  targeted  d is­
ru p tio n s  d id  n o t seem  to  a lter th e ir  p lu r ip o te n t p o ten tia l. I 
believe th a t th is  paper was p ivo ta l in  th e  dev e lo p m en t of th e  
field by en cou rag ing  o th e r investigators to  beg in  use of gene 
ta rg e tin g  in  m ice as a m eans for d e te rm in in g  th e  fu n c tio n  in  
th e  in ta c t an im a l of th e  genes th ey  w ere studying .
T he ra tio  of hom ologous to  n o n -h o m o lo g o u s  reco m b in a ­
tio n  events in  ES cells was found  to  be approx im ate ly  1 to  
1,000 (ref. 46). Because th e  d is ru p tio n  of m ost genes does n o t 
p roduce  a p h en o ty p e  th a t is selectable a t th e  cellular level, in ­
vestigators seeking specific gene d isrup tions w ou ld  n eed  e i­
th e r  to  u n d ertak e  ted ious DNA screens th ro u g h  m an y  cell
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colonies to  iden tify  the  rare ones co n ta in in g  th e  desired ta r­
geting  events or to use a selection  p ro to co l to  en rich  for cells 
co n ta in in g  such  events.
In  1988 we reported  a general strategy to  en rich  for cells in  
w h ich  hom ologous ta rge ting  even ts had  occurred50. This en ­
r ich m en t p rocedure, k now n  as p o sitive-nega tive  selection , 
has tw o co m p o n en ts  (Fig. 3). O ne c o m p o n en t is a positive se­
lectab le  gene, neo1, used to  select for rec ip ien t cells th a t have 
inco rpo ra ted  th e  ta rge ting  vector anyw here in  the ir genom es 
(th a t is, at the  target site by hom ologous reco m b in a tio n  or at 
ran d o m  sites by n o n -h o m o lo g o u s recom bina tion ). The sec­
ond  co m p o n en t is a negative selectable gene, HSV-tk, located  
at the  end of th e  linearized targeting  vector and  used to  select 
against cells co n ta in in g  ran d o m  in sertions of th e  target vec­
tor. Thus th e  'p o sitiv e ' se lection  enriches for rec ip ien t cells 
th a t have inco rpo ra ted  th e  in tro d u ced  vector and  th e  'n eg a ­
tive ' selec tion  e lim inates those th a t have inco rpo ra ted  it at 
n o n -h o m o lo g o u s sites. T he n e t effect is e n rich m en t for cells 
in  w h ich  the  desired ta rge ting  even t has occurred . The 
s tren g th  of th is e n rich m en t p rocedure  is th a t it is in d e p e n ­
d en t of th e  fu n c tio n  of th e  gene th a t is b e in g  d isrup ted  and 
succeeds w h e th e r or n o t the  gene is expressed in  cu ltu red  ES 
cells. P ositive-negative selection  has becom e th e  m ost fre­
quen tly  used procedure  to  en rich  for cells co n ta in in g  gene- 
ta rge ting  events.
Subsequent development and extension
The use of gene targeting  to  evaluate th e  fu nc tions of genes in  
th e  liv ing  m ouse is now  a ro u tin e  p rocedure  and  is used in  
h u n d red s  of laboratories all over the  w orld. It is g ratify ing  to 
be able to p ick up a lm ost any m ajo r b io logical jo u rn a l and 
find  th e  descrip tion  of yet a n o th e r 'k n o ck o u t' m ouse. The in 
vivo fu nc tions of well over 7,000 genes have been  analyzed 
w ith  gene targeting , a n u m b er th a t is very im pressive given 
th a t g en era tio n  of th is large co llec tion  of m ouse lines w ith  
targeted  m u ta tio n s  has been  accom plished  by in d e p e n d e n t 
investigators w ith o u t th e  b en efit of any special g o v ern m en t 
program  to  fund  it.
The gene-targeting  p ro toco l is now  done as follows: The de­
sired DNA sequence m o d ifica tion  is in tro d u ced  in to  a cloned 
copy of the  chosen  gene by s tandard  reco m b in an t DNA tech ­
nology . T hen , th e  m o d ifica tion  is transferred , by m eans of 
h om ologous reco m b in a tio n , to  th e  cognate  genom ic locus in  
ES cells and  the  ES cell lines carry ing  the  desired a lte ra tio n  are 
selected. Finally, ES cells co n ta in in g  th e  altered  genetic  locus 
are in jec ted  in to  m ouse b lastocysts, w h ich  are in  tu rn  
b ro u g h t to  term  by surgical transfer to foster m o th ers , gener­
a tin g  ch im eric  m ice th a t are capable of tran sm ittin g  the  m o d ­
ified genetic  locus to th e ir offspring. Figure 4 ou tlines these 
steps, from  the  iso la tion  of cu ltu red  ES cell lines c o n ta in in g  
th e  desired targeted  gene m o d ifica tion  to  th e  gen era tio n  of 
germ line chim eras and  th e ir offspring.
So far, gene ta rge ting  has b een  used m ain ly  to  d isru p t ch o ­
sen  genes to d e te rm ine  the ir fu n c tio n  in  m ice (th a t is, to 
generate  'k n o ck o u t' m ice). H owever, it can be used to m an ip ­
ulate  th e  m ouse genom e in  any desired m an n er. For exam ple, 
an  allelic series of m u ta tio n s  in  a specific gene can  be 
g enerated  to evaluate  th e  effects of changes re su lting  from  
ga in -o f-func tion  or partia l loss-of-function  m u ta tio n s , in  ad ­
d itio n  to  those  produced  by sim ple, com plete  loss-of-func- 
tio n  m u ta tio n s . F urtherm ore, to  p erm it th e  eva lua tion  of 
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Fig. 4 Generation of mouse germline chimeras from ES cells containing 
a targeted mutation, a, The first step involves the isolation of a clonal ES 
cell line containing the desired mutations. Positive-negative selection 
(Fig. 3) is used to enrich for ES cells containing the desired modified 
gene, b, The second step is to use those ES cells to generate chimeric 
mice able to transmit the m utant gene to their progeny. To facilitate iso­
lation of the desired progeny, the ES cells and recipient blastocysts are 
derived from mice with distinguishable coat color alleles (ES, agouti 
brown mice; blastocyst, black mice). This permits evaluation of the ex­
tent of chimerism by coat color chimerism and evaluation of ES cell con­
tribution to the formation of the germ line by the coat color of the 
progeny derived from the chimeric animals.
o f-func tion  allele com prom ises th e  em bryo  at early stages of 
deve lopm en t, the  Cre-loxP and  Flp/FRT site-specific recom bi­
n a tio n  system s, in  concert w ith  gene targeting , can  be used to 
generate  co n d itio n a l m u ta tio n s  th a t restric t the  effect of a 
m u ta tio n  to  specific cells, tissues or tem pora l periods51. In  
conclusion , a very b road  range of genetic  m an ip u la tio n s  in  
the  m ouse has been  m ade available th ro u g h  gene targeting . It 
is h oped  th a t use of th is techno logy  will pe rm it the  discovery 
of essen tial co m p o n en ts  u n d erly ing  even very com plex  b io ­
logical p h en o m en a  such  as h ig h er cognitive fu n c tio n  and 
dysfunction . W ith  th e  recen t pub lica tio n  of th e  com plete  se­
quences for h u m a n  and  m ouse genom es, p rac titioners of 
gene targeting  in  m ice have a b o u n ty  of in fo rm a tio n  for co n ­
version  to a fu n c tio n a l foo ting . The tran sfo rm atio n  of 
h u m a n  m ed ic ine  re su ltin g  fro m  th e  tra n s la tio n  o f th is new  
know ledge base m ay m ake to m o rro w 's  m ed ic in e  u n reco g ­
n izab le  re la tiv e  to  to d ay 's  p rac tices .
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